603259 药明康德
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额17,203,16212,406,51513,386,91210,616,0304,589,289
投资活动产生之现金流量净额(1,945,110)(5,518,177)(7,560,534)(9,690,286)(4,838,953)
筹资活动产生之现金流量净额1,123,541(3,832,191)(3,941,384)(1,277,808)(1,723,914)
汇率变动对现金及现金等价物的影响(370,473)387,525132,140160,633(79,143)
现金及现金等价物净增加/(减少)16,011,1193,443,6722,017,135(191,432)(2,052,721)
期初现金及现金等价物余额13,444,71110,001,0397,983,9048,175,33610,228,057
期末现金及现金等价物余额29,455,83113,444,71110,001,0397,983,9048,175,336